Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Evaluation of the Efficacy of Ambu® aScope for Intubation in Cancer Tongue

NCT03999476
completednot_applicable

Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients

NCT02724956
completednot_applicable

Evaluation of the Ambu ® aScope® for Tracheal Intubation in Difficult Airways

NCT01467739

Clinical Trials (3)

Showing 3 of 3 trials
NCT03999476Not Applicable

Evaluation of the Efficacy of Ambu® aScope for Intubation in Cancer Tongue

Completed
NCT02724956Not Applicable

Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients

Completed
NCT01467739Not Applicable

Evaluation of the Ambu ® aScope® for Tracheal Intubation in Difficult Airways

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3